Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Integrative omics reveals MYCN as a global suppressor of cellular signalling and enables network-based therapeutic target discovery in neuroblastoma

11 Dec 2015

Abstract excerpt

// David J. Duffy 1,7,* , Aleksandar Krstic 1,* , Melinda Halasz 1,* , Thomas Schwarzl 1,8,* , Dirk Fey 1 , Kristiina Iljin 6 , Jai Prakash Mehta 1 , Kate Killick 1 , Jenny Whilde 1 , Benedetta Turriziani 1 , Saija Haapa-Paananen 6 , Vidal Fey 6 , Matthias Fischer 5 , Frank Westermann 4 , Kai-Oliver Henrich 4 , Steffen Bannert 4 , Desmond G. Higgins 1,2,3 and Walter Kolch 1,2,3 1 Systems Biology Ireland,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer, Hypoxia, and Metabolism
Share to Neuroblastoma Research and Treatments
Share to Protein Degradation and Inhibitors

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 26673823
DOI: 10.18632/oncotarget.6568

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Integrative omics reveals MYCN as a global suppressor of cellular signalling and enables network-based therapeutic target discovery in neuroblastomaPMID 26673823Read ↗

Unveiling MYCN regulatory networks in neuroblastoma via integrative analysis of heterogeneous genomics dataSemantic proximity Read ↗

A comparative network analysis of high-risk MYCN amplified and high-risk MYCN non-amplified neuroblastoma patientsSemantic proximity Read ↗

Molecular targeting therapies for neuroblastoma: Progress and challengesSemantic proximity Read ↗

Dissection of the oncogenic MYCN transcriptional network reveals a large set of clinically relevant cell cycle genes as drivers of neuroblastoma tumorigenesisSemantic proximity Read ↗

MYCN in Neuroblastoma: “Old Wine into New Wineskins”Semantic proximity Read ↗

Bioinformatic analysis of the inner heterogeneity within MYCN non-amplified pediatric neuroblastoma sub-groupSemantic proximity Read ↗

Molecular mechanisms and therapeutic targets in neuroblastomaSemantic proximity Read ↗

MYCN-targeting miRNAs are predominantly downregulated during MYCN-driven neuroblastoma tumor formationSemantic proximity Read ↗

Accumulation of potential driver genes with genomic alterations predicts survival of high-risk neuroblastoma patientsSemantic proximity Read ↗

Prognostic significance of MYCN related genes in pediatric neuroblastoma: a study based on TARGET and GEO datasetsSemantic proximity Read ↗

Neuroblastoma, a Paradigm for Big Data Science in Pediatric OncologySemantic proximity Read ↗

MYCN acts as a direct co-regulator of p53 in MYCN amplified neuroblastomaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.